We have Priceline (400+) and some of the independent chains...

We have Priceline (400+) and some of the independent chains including National Pharmacies (50+) and Blooms (80+).

See Slide 19.
http://www.asx.com.au/asxpdf/20170320/pdf/43gxcf5jtd5r7b.pdf



I suspect Management will target Memocare next to collect another ~100k users.
http://www.guildlink.com.au/guildcare/products/memocare/

MDR listed at 3c in December 2015 with 100,000 connected patients. Sure the register has been diluted a little with a CR to support acquisitions, but here we are 18 months later climbing to 1M subscribers and the share price is ....... 3c.

There has been no announcements to advise substantial holders leaving, so the instos who hold 25% are still on board.

Find future niches, research companies with a resource, product, or service, and invest heavily in the silence, then ride the wave of momentum when the story unfolds.